| Common name: | RAD9 |
| Defline: | DNA damage checkpoint protein; (1 of 1) K10994 - cell cycle checkpoint control protein RAD9A [EC:3.1.11.2] (RAD9A) |
| Description: | Forms a sliding clamp complex with Hus1 and Rad1 that mediates repair at sites of DNA damage. Homolog of yeast DDC1 [PMID: 17992532] |
| Synonyms: | g16443.t1 |
| Chromosome: | chromosome 16 |
A plasmid for expressing Cre16.g682950 tagged with the fluorescent protein Venus and affinity epitope 3xFLAG is available: pLM005-Cre16.g682950-Venus-3xFLAG
No localization data is available in our datasets for this protein.
We did not determine any protein-protein interactions for this gene.
| Insertion Junction | Mutant Strain | Insertion Junction Feature | Confidence (%) | Genome Version |
|---|---|---|---|---|
| CLIP2.002591_1 | CLIP2.002591 | CDS | 80 | 6.1 |
| CLIP2.003891_1 | CLIP2.003891 | CDS | 63 | 6.1 |
| CLIP2.004416_1 | CLIP2.004416 | CDS | 63 | 6.1 |
| CLIP2.004790_1 | CLIP2.004790 | CDS | 80 | 6.1 |
| CLIP2.004790_2 | CLIP2.004790 | CDS | 80 | 6.1 |
| CLIP2.006723_1 | CLIP2.006723 | intron | 80 | 6.1 |
| CLIP2.006723_2 | CLIP2.006723 | intron | 80 | 6.1 |
| LMJ.RY0402.043270_1 | LMJ.RY0402.043270 | intron | 95 | 5.5 |
| LMJ.RY0402.043270_2 | LMJ.RY0402.043270 | intron | 95 | 5.5 |
| LMJ.RY0402.046759_1 | LMJ.RY0402.046759 | intron | 73 | 5.5 |
| LMJ.RY0402.050655_1 | LMJ.RY0402.050655 | CDS | 95 | 5.5 |
| LMJ.RY0402.050655_2 | LMJ.RY0402.050655 | CDS | 95 | 5.5 |
| LMJ.RY0402.159134_2 | LMJ.RY0402.159134 | intron | 95 | 5.5 |
| LMJ.RY0402.159134_3 | LMJ.RY0402.159134 | intron | 95 | 5.5 |
| PFAM: | PF04139 |
| PANTHER: | PTHR15237 |
| KEGG_ec: | EC:3.1.11.2 |
| KEGG_orthology: | K10994 |
| KOG: | |
| Gene ontology terms:: | GO:0000075, GO:0000077, GO:0006281, GO:0030896 |
| Best arabidopsis TAIR name: | AT3G05480.1 |
| Best arabidopsis TAIR symbol: | ATRAD9,RAD9 |
| Best arabidopsis TAIR defline: | cell cycle checkpoint control protein family |
| Phytozome Locus Page |
Mutants in this gene exhibit a phenotype under the following conditions:
| Cisplatin, screen 1 of 4 ( 99% confidence (FDR = 0.0014)) |
| Cisplatin, screen 2 of 4 ( 99% confidence (FDR = 0.00056)) |
| Cisplatin, screen 3 of 4 ( 99% confidence (FDR = 0.0005)) |
| Cisplatin, screen 4 of 4 ( 99% confidence (FDR = 0.0028)) |
| Mannitol, screen 1 of 1 ( 75% confidence (FDR = 0.25)) |
| Methyl methanesulfonate, screen 3 of 4 ( 99% confidence (FDR = 0.00078)) |
| Methyl methanesulfonate, screen 4 of 4 ( 99% confidence (FDR = 0.0014)) |
| Mitomycin C, screen 2 of 4 ( 99% confidence (FDR = 0.00016)) |
| Mitomycin C, screen 3 of 4 ( 99% confidence (FDR = 0.0016)) |
| Mitomycin C, screen 4 of 4 ( 99% confidence (FDR = 0.0016)) |
| Zeocin, screen 3 of 5 ( 94% confidence (FDR = 0.051)) |
| Zeocin, screen 4 of 5 ( 98% confidence (FDR = 0.02)) |
| Zeocin, screen 5 of 5 ( 99% confidence (FDR = 0.0011)) |
Note: FDR indicates the likelihood that a particular genotype-phenotype relationship is incorrect. Not all mutants in a particular gene show the same phenotype. Please see the mutant pages for each mutant's phenotypes. Complementation is needed to definitively prove a genotype-phenotype link. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.